Publication | Closed Access

Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization

C7e3 FabPercutaneous Coronary InterventionThrombosisPatients TreatedCardiovascular DiseaseBlood PlateletHematologyAnticoagulantPlatelet AntagonistMedicinePercutaneous Coronary RevascularizationCardiologyHeparinsAcute Myocardial Infarction